Playing the Priority Review Market: The Rules for Buyers and Sellers

Before the "Treat-and-Trade" program can begin, FDA will have to issue vouchers that can then be put up for sale-and buyers will have to understand the process for cashing them in. Here is a primer on the rules of the voucher program.

The process begins with the approval of a new drug or vaccine for a statutorily defined "tropical disease." It ends—in theory at least—with FDA reviewing another application within six months, even though the drug would normally not qualify for priority status. Also see "Treat and Trade: The New Priority Review Voucher Market" - Pink Sheet, 1 July, 2008.

In between, both the buyer and seller will have to make sure they understand the rules.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet